CCEL logo

Cryo-Cell International (CCEL) Accounts Receivable

Annual Accounts Receivable

$6.58 M
+$532.30 K+8.81%

November 30, 2023

Summary

Performance

1-Year Change

+8.81%

3-Year Change

+4%

5-Year Change

+12.08%

15-Year Change

+28.3%

CCEL Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.22%
CCEL annual accounts receivable is higher than 43.22% of companies in Healthcare sector

High & Low

All-time High

$6.58 M
CCEL annual accounts receivable is currently at an all-time high

3-Year Low

$5.25 M
CCEL annual accounts receivable is currently +25.18% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Nov 30, 2023
CCEL previous annual earnings announcement was published on Nov 30, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CCEL next annual earnings announcement is scheduled for Feb 28, 2025

OtherCCELbalance sheetmetrics:

Annual Accounts Payable

$3.17 M
CCEL annual accounts payable is $3.17 million

Annual Total Assets

$61.22 M
CCEL annual total assets is $61.22 million

Annual Total Liabilities

$72.25 M
CCEL annual total liabilities is $72.25 million

Annual Cash & Cash Equivalents

$406.10 K
CCEL annual cash & cash equivalents is $406.10 thousand

Quarterly Accounts Receivable

$6.87 M
+$42.20 K+0.62%

August 1, 2024

Summary

Performance

3-Month Change

+0.62%

1-Year Change

+4.52%

3-Year Change

+4.52%

5-Year Change

+4.52%

CCEL Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.27%
CCEL quarterly accounts receivable is higher than 42.27% of companies in Healthcare sector

High & Low

All-time High

$6.87 M
CCEL quarterly accounts receivable is currently at an all-time high

3-Year Low

$5.15 M
CCEL quarterly accounts receivable is currently +33.46% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Aug 1, 2024
CCEL previous earnings announcement was published on Aug 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CCEL next earnings announcement is scheduled for Feb 28, 2025

OtherCCELbalance sheetmetrics:

Quarterly Accounts Payable

$2.00 M
CCEL quarterly accounts payable is $2.00 million

Quarterly Total Assets

$62.93 M
CCEL quarterly total assets is $62.93 million

Quarterly Total Liabilities

$72.49 M
CCEL quarterly total liabilities is $72.49 million

Quarterly Cash And Cash Equivalents

$197.40 K
CCEL quarterly cash and cash equivalents is $197.40 thousand

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

CCEL Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.8%+4.5%
3 y3 years+4.0%+4.5%
5 y5 years+12.1%+4.5%

CCEL Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+25.2%at high+33.5%
5 y5-yearat high+25.2%at high+33.5%
alltimeall timeat high+2954.4%at high+3812.1%

Cryo-Cell International Accounts Receivable History

DateAnnualQuarterly
Aug 2024
-
$6.87 M(+0.6%)
May 2024
-
$6.83 M(+1.6%)
Feb 2024
-
$6.73 M(+2.3%)
Nov 2023
$6.58 M(+8.8%)
$6.58 M(+2.2%)
Aug 2023
-
$6.44 M(-3.7%)
May 2023
-
$6.68 M(+2.5%)
Feb 2023
-
$6.52 M(+7.9%)
Nov 2022
$6.04 M(+15.1%)
$6.04 M(+13.0%)
Aug 2022
-
$5.35 M(+3.8%)
May 2022
-
$5.15 M(-0.0%)
Feb 2022
-
$5.15 M(-1.9%)
Nov 2021
$5.25 M(-16.9%)
$5.25 M(-3.6%)
Aug 2021
-
$5.45 M(+4.5%)
May 2021
-
$5.22 M(-7.5%)
Feb 2021
-
$5.64 M(-10.8%)
Nov 2020
$6.32 M(+3.7%)
$6.32 M(-2.8%)
Aug 2020
-
$6.50 M(+8.9%)
May 2020
-
$5.97 M(+3.6%)
Feb 2020
-
$5.77 M(-5.4%)
Nov 2019
$6.10 M(+3.9%)
$6.10 M(+3.6%)
Aug 2019
-
$5.89 M(+2.2%)
May 2019
-
$5.76 M(+1.1%)
Feb 2019
-
$5.69 M(-3.0%)
Nov 2018
$5.87 M(+14.5%)
$5.87 M(+6.4%)
Aug 2018
-
$5.51 M(+14.4%)
May 2018
-
$4.82 M(-2.2%)
Feb 2018
-
$4.93 M(-3.9%)
Nov 2017
$5.13 M(+26.5%)
$5.13 M(+5.4%)
Aug 2017
-
$4.86 M(+6.7%)
May 2017
-
$4.56 M(+2.4%)
Feb 2017
-
$4.45 M(+9.8%)
Nov 2016
$4.05 M(+32.5%)
$4.05 M(-7.5%)
Aug 2016
-
$4.38 M(+18.4%)
May 2016
-
$3.70 M(+15.1%)
Feb 2016
-
$3.22 M(+5.2%)
Nov 2015
$3.06 M(-24.9%)
$3.06 M(-26.5%)
Aug 2015
-
$4.16 M(+12.3%)
May 2015
-
$3.71 M(-11.7%)
Feb 2015
-
$4.20 M(+3.1%)
Nov 2014
$4.07 M(+22.0%)
$4.07 M(+3.1%)
Aug 2014
-
$3.95 M(-3.5%)
May 2014
-
$4.10 M(+10.6%)
Feb 2014
-
$3.70 M(+11.0%)
Nov 2013
$3.34 M(+17.6%)
$3.34 M(-6.7%)
Aug 2013
-
$3.58 M(+0.3%)
May 2013
-
$3.57 M(+6.2%)
Feb 2013
-
$3.36 M(+18.4%)
DateAnnualQuarterly
Nov 2012
$2.84 M(-7.3%)
$2.84 M(-15.8%)
Aug 2012
-
$3.37 M(+2.3%)
May 2012
-
$3.29 M(+2.6%)
Feb 2012
-
$3.21 M(+4.9%)
Nov 2011
$3.06 M(+29.8%)
$3.06 M(+19.2%)
Aug 2011
-
$2.57 M(-22.6%)
May 2011
-
$3.32 M(+26.4%)
Feb 2011
-
$2.62 M(+11.4%)
Nov 2010
$2.36 M(+4.9%)
$2.36 M(+6.0%)
Aug 2010
-
$2.22 M(-6.9%)
May 2010
-
$2.39 M(+6.3%)
Feb 2010
-
$2.25 M(+0.0%)
Nov 2009
$2.25 M(-0.2%)
$2.25 M(+19.1%)
Aug 2009
-
$1.89 M(-2.9%)
May 2009
-
$1.94 M(+31.0%)
Feb 2009
-
$1.48 M(-34.1%)
Nov 2008
$2.25 M(-7.4%)
$2.25 M(+23.4%)
Aug 2008
-
$1.82 M(-5.1%)
May 2008
-
$1.92 M(+14.6%)
Feb 2008
-
$1.68 M(-31.0%)
Nov 2007
$2.43 M(+100.4%)
$2.43 M(+18.9%)
Aug 2007
-
$2.04 M(+1.9%)
May 2007
-
$2.01 M(+29.7%)
Feb 2007
-
$1.55 M(+27.4%)
Nov 2006
$1.21 M(+16.3%)
$1.21 M(-1.0%)
Aug 2006
-
$1.23 M(+47.0%)
May 2006
-
$833.40 K(-5.8%)
Feb 2006
-
$884.80 K(-15.2%)
Nov 2005
$1.04 M(-0.1%)
$1.04 M(-7.2%)
Aug 2005
-
$1.13 M(-8.4%)
May 2005
-
$1.23 M(+15.8%)
Feb 2005
-
$1.06 M(+1.6%)
Nov 2004
$1.04 M(+115.8%)
$1.04 M(+24.2%)
Aug 2004
-
$841.00 K(+12.8%)
May 2004
-
$745.50 K(+9.5%)
Feb 2004
-
$680.70 K(+40.7%)
Nov 2003
$483.90 K(+71.7%)
$483.90 K(+54.5%)
Aug 2003
-
$313.20 K(+58.5%)
May 2003
-
$197.60 K(-40.4%)
Feb 2003
-
$331.70 K(+17.7%)
Nov 2002
$281.90 K(+30.9%)
$281.90 K(+5.9%)
Aug 2002
-
$266.30 K(+2.2%)
May 2002
-
$260.60 K(+43.7%)
Feb 2002
-
$181.30 K(-15.8%)
Nov 2001
$215.30 K
$215.30 K(+1.2%)
Aug 2001
-
$212.70 K(+21.1%)
May 2001
-
$175.70 K

FAQ

  • What is Cryo-Cell International annual accounts receivable?
  • What is the all time high annual accounts receivable for Cryo-Cell International?
  • What is Cryo-Cell International annual accounts receivable year-on-year change?
  • What is Cryo-Cell International quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Cryo-Cell International?
  • What is Cryo-Cell International quarterly accounts receivable year-on-year change?

What is Cryo-Cell International annual accounts receivable?

The current annual accounts receivable of CCEL is $6.58 M

What is the all time high annual accounts receivable for Cryo-Cell International?

Cryo-Cell International all-time high annual accounts receivable is $6.58 M

What is Cryo-Cell International annual accounts receivable year-on-year change?

Over the past year, CCEL annual accounts receivable has changed by +$532.30 K (+8.81%)

What is Cryo-Cell International quarterly accounts receivable?

The current quarterly accounts receivable of CCEL is $6.87 M

What is the all time high quarterly accounts receivable for Cryo-Cell International?

Cryo-Cell International all-time high quarterly accounts receivable is $6.87 M

What is Cryo-Cell International quarterly accounts receivable year-on-year change?

Over the past year, CCEL quarterly accounts receivable has changed by +$297.40 K (+4.52%)